Clinical trials of antiphlogistic agent series in treating chronic nonbacterial prostatitis.
- Author:
Shao-Fang PENG
1
;
Zhi-Zhong YANG
;
Xiao-Fen LIN
;
Shao-Fen LI
;
Zi XIE
;
Jing CAI
;
Li-Chao YU
Author Information
- Publication Type:Clinical Trial
- MeSH: Adult; Chronic Disease; Humans; Male; Medicine, Chinese Traditional; Middle Aged; Prostatitis; drug therapy
- From: National Journal of Andrology 2003;9(9):716-719
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the curative effect of antiphlogistic agent series on treating chronic nonbacterial prostatitis (CNP).
METHODSOne hundred and sixty patients were randomized into 4 groups for an 8-week clinical observation: group A (oral antiphlogistic medicinal granules only), group B (oral antiphlogistic medicinal granules + retention enema), group C (oral antiphlogistic medicinal granules + rectal), and group D (antiphlogistic medicinal granules + rectally + hip bath). Single blind trials were employed.
RESULTSThe curative rates of the 4 groups were 37.5%, 57.5%, 52.5% and 82.5% respectively, while the total efficacy rates were 42.5%, 82.5%, 77.5% and 92.5% respectively. Compared with groups A, B and C, the curative rate of group D was significantly higher (P < 0.05). The difference in efficacy rates was slight between groups B and D (P < 0.05), but significant between groups A and C (P < 0.05).
CONCLUSIONSCombined treatment therapy can improve the effect of CNP treatment and clear away heat and toxic material. The antiphlogistic agent series, with the effect of motivating blood circulation and removing blood stasis, turned out to be an effective traditional Chinese medicine in treating CNP.